Cargando…

Community Environmental Contamination of Toxigenic Clostridium difficile

BACKGROUND: Clostridium difficile infection is often considered to result from recent acquisition of a C difficile isolate in a healthcare setting. However, C difficile spores can persist for long periods of time, suggesting a potentially large community environmental reservoir. The objectives of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alam, M Jahangir, Walk, Seth T., Endres, Bradley T., Basseres, Eugenie, Khaleduzzaman, Mohammed, Amadio, Jonathan, Musick, William L., Christensen, Jennifer L., Kuo, Julie, Atmar, Robert L., Garey, Kevin W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414050/ https://www.ncbi.nlm.nih.gov/pubmed/28480289 http://dx.doi.org/10.1093/ofid/ofx018

Ejemplares similares

Impact on toxin production and cell morphology in Clostridium difficile by ridinilazole (SMT19969), a novel treatment for C. difficile infection
por: Bassères, Eugénie, et al.
Publicado: (2016)

Epidemic Clostridioides difficile Ribotype 027 Lineages: Comparisons of Texas Versus Worldwide Strains
por: Endres, Bradley T, et al.
Publicado: (2019)

Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection
por: Carlson, Travis J, et al.
Publicado: (2020)

510. First Environmental Investigation of Toxigenic Clostridium difficile Strains in Texas Hospitals
por: Alam, M Jahangir, et al.
Publicado: (2018)

First Environmental Investigation of Toxigenic Clostridium difficile at a Large Hospital in Bangladesh
por: Alam, M Jahangir, et al.
Publicado: (2017)

A pilot study to assess bacterial and toxin reduction in patients with Clostridium difficile infection given fidaxomicin or vancomycin
por: Thabit, Abrar K., et al.
Publicado: (2016)

1369. Combined Analysis of the In Vitro Activity of Ridinilazole (RDZ) Against More Than 500 Clostridium difficile (CD) Clinical Isolates and Impact of RDZ on Cell Morphology
por: Duperchy, Esther, et al.
Publicado: (2018)

An Analysis of Clostridium difficile Environmental Contamination During and After Treatment for C difficile Infection
por: Davies, Kerrie, et al.
Publicado: (2020)

Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples
por: Kilic, Abdullah, et al.
Publicado: (2015)

Efficacy of Bezlotoxumab in Participants Receiving Metronidazole, Vancomycin, or Fidaxomicin for Treatment of Clostridioides (Clostridium) difficile Infection
por: Dubberke, Erik R, et al.
Publicado: (2020)

688. In Vitro Activity of Eravacycline, a New Tetracycline Analog, and Comparators Against the Six Most Commonly Isolated Ribotypes of Clostridioides difficile
por: Basseres, Eugenie, et al.
Publicado: (2019)

Protective Effects of Bifidobacterial Strains Against Toxigenic Clostridium difficile
por: Wei, Yanxia, et al.
Publicado: (2018)

Diagnosis of Clostridium difficile infection by toxigenic culture and PCR assay
por: Mirzaei, Elnaze Zare, et al.
Publicado: (2018)

Clostridium difficile Enteritis With NAP7/078 Toxigenic Strain
por: Zewude, Rahel T, et al.
Publicado: (2023)

Assessment of Kidney Injury as a Severity Criteria for Clostridioides Difficile Infection
por: Carlson, Travis J, et al.
Publicado: (2020)

Incidence and Costs of Clostridium difficile Infections in Canada
por: Levy, Adrian R., et al.
Publicado: (2015)

Clinical importance and representation of toxigenic and non-toxigenic Clostridium difficile cultivated from stool samples of hospitalized patients
por: Predrag, Stojanovic, et al.
Publicado: (2012)

Reduced Susceptibility to Metronidazole Is Associated With Initial Clinical Failure in Clostridioides difficile Infection
por: Gonzales-Luna, Anne J, et al.
Publicado: (2021)

In vitro activity of eravacycline against common ribotypes of Clostridioides difficile
por: Bassères, Eugénie, et al.
Publicado: (2020)

Impacts of infection with different toxigenic Clostridium difficile strains on faecal microbiota in children
por: Ling, Zongxin, et al.
Publicado: (2014)

High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia
por: Moono, Peter, et al.
Publicado: (2017)

Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study
por: Zhang, Xiaoxia, et al.
Publicado: (2016)

Prevalence of Clostridium difficile and its toxigenic genotype in beef samples in west of Iran
por: Kheradmand, Malihe, et al.
Publicado: (2017)

Prevalence and antimicrobial susceptibility pattern of toxigenic Clostridium difficile strains isolated in Iran
por: MOHAMMADBEIGI, Maryam, et al.
Publicado: (2019)

In Vitro Activity of Omadacycline, a New Tetracycline Analog, and Comparators against Clostridioides difficile
por: Begum, Khurshida, et al.
Publicado: (2020)

Comparison of a frozen human foreskin fibroblast cell assay to an enzyme immunoassay and toxigenic culture for the detection of toxigenic Clostridium difficile()()()
por: Strachan, Alastair J., et al.
Publicado: (2013)

Detection of toxigenic Clostridium difficile colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation
por: Vaughn, John L., et al.
Publicado: (2018)

Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile
por: Wiens, Jenna, et al.
Publicado: (2014)

Changing Results to Change Results: Nudging Antimicrobial Prescribing for Clostridium difficile
por: Herman, Dakoda J, et al.
Publicado: (2020)

Determinants of Clostridium difficile Infection Incidence Across Diverse United States Geographic Locations
por: Lessa, Fernanda C., et al.
Publicado: (2014)

Association Between Outpatient Antibiotic Prescribing Practices and Community-Associated Clostridium difficile Infection
por: Dantes, Raymund, et al.
Publicado: (2015)

Towards Development of a Non-Toxigenic Clostridioides difficile Oral Spore Vaccine against Toxigenic C. difficile
por: Hughes, Jaime, et al.
Publicado: (2022)

Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers
por: Brouwer, Michael S.M., et al.
Publicado: (2013)

Longitudinal investigation of carriage rates and genotypes of toxigenic Clostridium difficile in hepatic cirrhosis patients
por: Chen, Yunbo, et al.
Publicado: (2019)

Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival
por: Behar, Laura, et al.
Publicado: (2017)

Enterococcus faecalis Isolated From Infant Feces Inhibits Toxigenic Clostridioides (Clostridium) difficile
por: Romyasamit, Chonticha, et al.
Publicado: (2020)

Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial( )
por: Garey, Kevin W, et al.
Publicado: (2022)

Risk Factors of Fecal Toxigenic or Non-Toxigenic Clostridium difficile Colonization: Impact of Toll-Like Receptor Polymorphisms and Prior Antibiotic Exposure
por: Hung, Yuan-Pin, et al.
Publicado: (2013)

Burden of Nursing Home-Onset Clostridium difficile Infection in the United States: Estimates of Incidence and Patient Outcomes
por: Hunter, Jennifer C., et al.
Publicado: (2016)

Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population
por: Olsen, Margaret A, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e710duidubkn9btuc9o73u0c44